Correction for Pageon et al., Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination

IMMUNOLOGY AND INFLAMMATION Correction for “Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination,” by Sophie V. Pageon, Thibault Tabarin, Yui Yamamoto, Yuanqing Ma, John S. Bridgeman, André Cohnen, Carola Benzing, Yijun Gao, Michael D. Crowther, Katie Tungatt, Garry Dolton, Andrew K. Sewell, David A. Price, Oreste Acuto, Robert G. Parton, J. Justin Gooding, Jérémie Rossy, Jamie Rossjohn, and Katharina Gaus, which appeared in issue 37, September 13, 2016, of Proc Natl Acad Sci USA (113:E5454–5463; first published August 29, 2016; 10.1073/pnas.1607436113).

The authors note that Philip R. Nicovich should be added to the author list between Yuanqing Ma and John S. Bridgeman. Philip R. Nicovich should be credited with contributing new reagents/analytic tools. The corrected author line, affiliation line, and author contributions appear below. The online version has been corrected.

Sophie V. Pageon^a,b,1, Thibault Tabarin^a,b,1, Yui Yamamoto^a,b,1, Yuanqing Ma^a,b, Philip R. Nicovich^a,b, John S. Bridgeman^c,d, André Cohnen^e, Carola Benzing^a,b, Yijun Gao^a,b, Michael D. Crowther^c, Katie Tungatt^c, Garry Dolton^c, Andrew K. Sewell^c, David A. Price^c,f, Oreste Acuto^e, Robert G. Parton^g,h,i, J. Justin Gooding^i,j, Jérémie Rossy^a,b, Jamie Rossjohn^c,k,l, and Katharina Gaus^a,b,2

^aEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; ^bAustralian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia; ^cInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom; ^dCellular Therapeutics Ltd., Manchester M13 9XX, United Kingdom; ^eT Cell Signalling Laboratory, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom; ^fHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; ^gInstitute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia; ^hAustralia Centre for Microscopy and Microanalysis, University of Queensland, St. Lucia, QLD 4072, Australia; ⁱAustralian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, St. Lucia, QLD 4072, Australia; ^jSchool of Chemistry and Australian Centre of NanoMedicine, University of New South Wales, Sydney, NSW 2052, Australia; ^kInfection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; and ^lAustralian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia

Author contributions: S.V.P., J. Rossy, J. Rossjohn, and K.G. designed research; S.V.P., Y.Y., Y.M., and Y.G. performed research; P.R.N., J.S.B., A.C., C.B., M.D.C., K.T., G.D., A.K.S., D.A.P., and O.A. contributed new reagents/analytic tools; S.V.P., T.T., and Y.Y. analyzed data; S.V.P., R.G.P., J.J.G., and K.G. wrote the paper.